THE DEFINITIVE GUIDE TO API PHARMACEUTICAL

“The current problem has uncovered some structural weaknesses inside the EU’s medicines source chain in addition to a higher dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides mentioned. She recommended that provide chain problems be resolved in an EU pharmaceutical strategy anticipated to become released by the